The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsHerbal medicines for fatty liver diseasesHerbal medicines for fatty liver diseasesNonalcoholic fatty liver disease: a comprehensive review of a growing epidemicThe blind men 'see' the elephant-the many faces of fatty liver diseaseAssociation between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort studyHepatitis C Virus, Insulin Resistance, and SteatosisNAFLD and Chronic Kidney DiseaseBidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeMetabolic syndrome in rheumatoid arthritisManagement of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionineThe Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know.Epidemiology of the metabolic syndrome in the USAAutophagy in the liver: cell's cannibalism and beyondHigh serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational studyWhat are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?Multifeature analysis of an ultrasound quantitative diagnostic index for classifying nonalcoholic fatty liver disease.Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease.Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging.Domain Analysis of Integrated Data to Reduce Cost Associated with Liver Disease.Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study.Detection of changes in the structure and distribution map of triacylglycerol in fatty liver model by MALDI-SpiralTOF.Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.The metabolic syndromeBenefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients.Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples.Endogenous catalase delays high-fat diet-induced liver injury in mice.Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patientsNonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort studyEnhanced amelioration of high-fat diet-induced fatty liver by docosahexaenoic acid and lysine supplementationsOverexpression of apolipoprotein A-I alleviates endoplasmic reticulum stress in hepatocytes.Metabolic syndrome: is equine disease comparable to what we know in humans?PPARalpha: energy combustion, hypolipidemia, inflammation and cancerNonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile.NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes.
P2860
Q22299426-E4B124B4-1C4E-4D38-AD3C-854817BBEBA9Q24200256-25BFC392-95C8-4A0E-A8CD-96777DDD147CQ24236298-C1340D0D-60E9-41E2-9956-BD7C182C79B4Q24563381-0D2F3EBE-C5DA-48F4-86E1-9390BC6CCD6EQ24654991-10ECBAD0-2651-4D90-AA4E-1DFE3E1677C7Q24658538-DFC2BF86-61F4-4DB6-9957-769209EAB851Q26751755-761108DC-22A3-418C-B7B6-8D2EB9BF9705Q26752759-4AB18CD8-0214-4720-935D-E8A5DADB122BQ26765455-A9C0E08D-BCEE-4732-B7AF-C733EB73728DQ26822038-670B0C33-2DF3-4268-9904-FBDD2D35444CQ26827665-65EBF36A-11C5-430A-8F62-8BF008A5296AQ26992163-FCD4B765-8B16-4569-A7E0-3C5E37980D0FQ27008277-421ED230-3DC0-4028-ADBA-89F1B0E01558Q28298801-E2212ABD-E2E0-4D2B-BEEC-3564F4D084B0Q28388115-BDFD1C9E-C783-4D5C-AC6B-4FAF5881D141Q28474831-57FC4FB4-6570-4139-AF2F-BC57D27C156DQ30361645-DBB74D40-6129-4F51-B132-3C750015B4DFQ30371936-6E436E3D-4B10-4298-B896-3C30A8DF687EQ30433234-8CBE3A71-4F12-4A5B-BC4B-4965F38BFECBQ30443852-8C9723FD-A4DA-453A-9ABC-410DF3F97A31Q30747665-8A1B4397-83F8-4EB5-A76C-4F8B8B549785Q30986369-40AFA811-B786-4081-9209-4E8A840A4EC4Q31060630-E1534368-BF27-419C-AE0B-5B03839732B8Q31154276-AD1329B1-459E-4296-B659-4C6F6809A7AEQ33397694-4112A1FE-8D74-4A8A-B194-19AED7D0AEC2Q33569142-5FA22DB0-F369-4DFE-8679-A9495ED77F3DQ33573638-91282A7C-3216-4DFC-9871-FD53BA1437CBQ33584317-BEE422F7-4AB8-4315-A259-FA0D54AD09DFQ33614752-FF0A6B9D-2B8C-4DE4-9848-E36B4038E98EQ33627037-A5DA8179-6081-48B7-AF53-E77CC88FF014Q33644131-6195DC50-2DE9-4AA0-AF9D-5B4FC2547158Q33748530-7F4E9386-C160-4A2B-933C-AC3CF6834735Q33755805-18241438-DD00-4AF9-B7CF-5537C0CA465CQ33796880-DBF5B463-58DC-4B09-85C8-1C02A88C6B1BQ33805104-FD2D708C-3273-404D-8FFE-14BCFFDC750EQ33820345-BCB87160-6B70-4EFF-9C17-3A076F0D6973Q33844463-3853A4A6-E7F6-47E1-A798-53C8FDDA413FQ33886948-E5059306-F370-4B70-8D90-E63F0C17D7AFQ33895173-FD99496D-DAFA-48A6-B673-5C9C86B77477Q33937311-57973701-7608-4160-BC84-246499DB1833
P2860
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
@ast
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
@en
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
@nl
type
label
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
@ast
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
@en
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
@nl
prefLabel
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
@ast
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
@en
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
@nl
P2093
P1476
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
@en
P2093
Hiroshi Sarui
Hiroya Taniguchi
Junichi Okuda
Kazunori Ida
Kota Fujii
Makoto Shimazaki
Masahide Hamaguchi
Noriyuki Takeda
Takahiro Kato
Takao Kojima
P304
P356
10.7326/0003-4819-143-10-200511150-00009
P407
P577
2005-11-01T00:00:00Z